Long Term Evaluation of Sevelamer HCl vs. Calcium-based Phosphate Binder in the Treatment of Hyperphosphatemia in Hemodialysis Patients

NCT01755078 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

166

Enrollment

INDUSTRY

Sponsor class

Conditions

Hemodialysis
Hyperphosphatemia
Cardiovascular Events

Interventions

DRUG: Sevelamer HCl
DRUG: Calcium-based phosphate binder

Sponsor

Chugai Pharma Taiwan